Knight Capital Group’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Knight Capital Group’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$59K	Buy	+6	New	+$66.5K	﹤0.01%	3034

Other funds holding FRTX

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Litespeed Management New York $48.2M AUM 9.81% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Knight Capital Group's FRTX Position: Q2 2013 in Review

Knight Capital Group opened a new position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q2 2013: 6 shares worth $59K. The stake represents ﹤0.01% of the portfolio and ranks #3034 among its holdings.

84 funds tracked by Wall St. Rank hold FRTX as of Q2 2013.

Knight Capital Group held 6 shares of Fresh Tracks Therapeutics, Inc. Common Stock worth $59K as of Q2 2013.
Fresh Tracks Therapeutics, Inc. Common Stock was a new Knight Capital Group position in Q2 2013.
Fresh Tracks Therapeutics, Inc. Common Stock made up ﹤0.01% of Knight Capital Group's portfolio in Q2 2013, its #3034 holding.
84 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.